These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 16048914)

  • 1. Role of the AcrAB-TolC efflux pump in determining susceptibility of Haemophilus influenzae to the novel peptide deformylase inhibitor LBM415.
    Dean CR; Narayan S; Daigle DM; Dzink-Fox JL; Puyang X; Bracken KR; Dean KE; Weidmann B; Yuan Z; Jain R; Ryder NS
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3129-35. PubMed ID: 16048914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced susceptibility of Haemophilus influenzae to the peptide deformylase inhibitor LBM415 can result from target protein overexpression due to amplified chromosomal def gene copy number.
    Dean CR; Narayan S; Richards J; Daigle DM; Esterow S; Leeds JA; Kamp H; Puyang X; Wiedmann B; Mueller D; Voshol H; van Oostrum J; Wall D; Koehn J; Dzink-Fox J; Ryder NS
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1004-10. PubMed ID: 17220413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of LBM415 compared to those of 11 other agents against Haemophilus species.
    Bogdanovich T; Smith KA; Clark C; Pankuch GA; Lin G; McGhee P; Dewasse B; Appelbaum PC
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2323-9. PubMed ID: 16801408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic evidence for functional interactions between TolC and AcrA proteins of a major antibiotic efflux pump of Escherichia coli.
    Gerken H; Misra R
    Mol Microbiol; 2004 Nov; 54(3):620-31. PubMed ID: 15491355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
    Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
    J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total alkaloids of Sophorea alopecuroides-induced down-regulation of AcrAB-TolC efflux pump reverses susceptibility to ciprofloxacin in clinical multidrug resistant Escherichia coli isolates.
    Zhou X; Jia F; Liu X; Wang Y
    Phytother Res; 2012 Nov; 26(11):1637-43. PubMed ID: 22371352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative antimicrobial characterization of LBM415 (NVP PDF-713), a new peptide deformylase inhibitor of clinical importance.
    Fritsche TR; Sader HS; Cleeland R; Jones RN
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1468-76. PubMed ID: 15793128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TolC but not AcrB is essential for multidrug-resistant Salmonella enterica serotype Typhimurium colonization of chicks.
    Baucheron S; Mouline C; Praud K; Chaslus-Dancla E; Cloeckaert A
    J Antimicrob Chemother; 2005 May; 55(5):707-12. PubMed ID: 15814604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the multidrug efflux operon acrEF by insertional activation with IS1 or IS10 elements in Salmonella enterica serovar typhimurium DT204 acrB mutants selected with fluoroquinolones.
    Olliver A; Vallé M; Chaslus-Dancla E; Cloeckaert A
    Antimicrob Agents Chemother; 2005 Jan; 49(1):289-301. PubMed ID: 15616308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antistaphylococcal activity of LBM415, a new peptide deformylase inhibitor, compared with those of other agents.
    Credito K; Lin G; Ednie LM; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Oct; 48(10):4033-6. PubMed ID: 15388473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of AcrEF in Quinolone Resistance Development in Escherichia coli When AcrAB-TolC Function Is Impaired.
    Zhang CZ; Chang MX; Yang L; Liu YY; Chen PX; Jiang HX
    Microb Drug Resist; 2018; 24(1):18-23. PubMed ID: 28520511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions underlying assembly of the Escherichia coli AcrAB-TolC multidrug efflux system.
    Touzé T; Eswaran J; Bokma E; Koronakis E; Hughes C; Koronakis V
    Mol Microbiol; 2004 Jul; 53(2):697-706. PubMed ID: 15228545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the Haemophilus influenzae tolC gene by susceptibility profiles of insertionally inactivated efflux pump mutants.
    Trepod CM; Mott JE
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1416-8. PubMed ID: 15047557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SmvA, and not AcrB, is the major efflux pump for acriflavine and related compounds in Salmonella enterica serovar Typhimurium.
    Villagra NA; Hidalgo AA; Santiviago CA; Saavedra CP; Mora GC
    J Antimicrob Chemother; 2008 Dec; 62(6):1273-6. PubMed ID: 18819967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipneumococcal activity of LBM415, a new peptide deformylase inhibitor, compared with those of other agents.
    Ednie LM; Pankuch G; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Oct; 48(10):4027-32. PubMed ID: 15388472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MarA-mediated overexpression of the AcrAB efflux pump results in decreased susceptibility to tigecycline in Escherichia coli.
    Keeney D; Ruzin A; McAleese F; Murphy E; Bradford PA
    J Antimicrob Chemother; 2008 Jan; 61(1):46-53. PubMed ID: 17967850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meropenem susceptibility breakpoint for Pseudomonas aeruginosa strains hyperproducing mexB mRNA.
    Giske CG; Borén C; Wretlind B; Kronvall G
    Clin Microbiol Infect; 2005 Aug; 11(8):662-9. PubMed ID: 16008620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino Acid Substitution in the Major Multidrug Efflux Transporter Protein AcrB Contributes to Low Susceptibility to Azithromycin in Haemophilus influenzae.
    Seyama S; Wajima T; Nakaminami H; Noguchi N
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel approach to mapping of resistance mutations in whole genomes by using restriction enzyme modulation of transformation efficiency.
    Lerner CG; Kakavas SJ; Wagner C; Chang RT; Merta PJ; Ruan X; Metzger RE; Beutel BA
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2767-77. PubMed ID: 15980348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of acrAB in antibiotic resistance of Haemophilus parasuis serovar 4.
    Feng S; Xu L; Xu C; Fan H; Liao M; Ren T
    Vet J; 2014 Oct; 202(1):191-4. PubMed ID: 25106806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.